[Federal Register Volume 87, Number 131 (Monday, July 11, 2022)]
[Notices]
[Page 41128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-14712]



[[Page 41128]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Advisory Committee on Breast 
Cancer in Young Women (ACBCYW). This meeting is open to the public, 
limited only by the number of audio and web conference lines (100 audio 
and web conference lines are available). Online registration is 
required.

DATES: The meeting will be held on August 23, 2022, from 11:00 a.m. to 
4:00 p.m., EDT.

ADDRESSES: All meeting participants must register online for the 
meeting at least 2 business days in advance at https://www.cdc.gov/cancer/breast/what_cdc_is_doing/meetings.htm. Please complete all the 
required fields and submit your registration no later than August 19, 
2022. Registered participants will receive the audio and web conference 
access instructions before the meeting.

FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA, 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 4770 Buford Highway NE, Mailstop 
S107-4, Atlanta, Georgia 30341; Telephone (404) 498-0073; Fax (770) 
488-4760; Email: <a href="/cdn-cgi/l/email-protection#51303233322826113235327f363e27"><span class="__cf_email__" data-cfemail="12737170716b65527176713c757d64">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation, and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Committee will assist in ensuring scientific 
quality, timeliness, utility, and dissemination of credible appropriate 
messages and resource materials.
    Matters to be Considered: The agenda will include discussions on 
current topics related to breast cancer in young women. These will 
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics, 
and Provider Engagement. Agenda items are subject to change as 
priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-14712 Filed 7-8-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>